{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:54:22Z","timestamp":1790787262055,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1053\/j.jvca.2024.09.135","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T22:19:02Z","timestamp":1728166742000},"page":"3188-3199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hydroxocobalamin Versus Methylene Blue for Treatment of Vasoplegic Shock Following Cardiopulmonary Bypass: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-2344","authenticated-orcid":false,"given":"Matthew","family":"Cadd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ultan","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gallop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Cabaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.09.135_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: The past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery\u2014Review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0004","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: A meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance","volume":"15","author":"Carrel","year":"2000","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0006","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on\u2013cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.09.135_bib0007","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00003246-199906000-00033","article-title":"Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass","volume":"27","author":"Kristof","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0008","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0022-5223(94)70355-8","article-title":"Vasoplegic syndrome: A new dilemma","volume":"107","author":"Gomes","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.09.135_bib0011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose IV hydroxocobalamin (Vitamin B12) in septic shock: A double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)","volume":"163","author":"Patel","year":"2023","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.09.135_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1053\/j.jvca.2024.09.135_bib0015","first-page":"1","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.09.135_bib0016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.jvca.2024.09.135_bib0017","unstructured":"Cochrane Collaboration. Review Manager (RevMan). Version 5.4 [computer program]. 2020."},{"key":"10.1053\/j.jvca.2024.09.135_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.09.135_bib0019","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1053\/j.jvca.2024.09.135_bib0021","unstructured":"Deeks JJ, Higgins JP, Altman DG. 9.5.2 Identifying and measuring heterogeneity. The Cochrane handbook for systematic reviews of interventions version 5.1. 2011; 5."},{"key":"10.1053\/j.jvca.2024.09.135_bib0022","unstructured":"Sterne J, Egger M, Moher D. Cochrane Collaboration. 10.4.3.1 Recommendations on testing for funnel plot asymmetry. Cochrane handbook for systematic reviews of interventions version. 2011; 5."},{"key":"10.1053\/j.jvca.2024.09.135_bib0023","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1053\/j.jvca.2018.11.020","article-title":"Methylene blue monotherapy compared with combination therapy with hydroxocobalamin for the treatment of refractory vasoplegic syndrome: A retrospective cohort study","volume":"33","author":"Feih","year":"2019","journal-title":"J Cardio-thorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0024","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/j.jvca.2020.01.033","article-title":"Hydroxocobalamin versus methylene blue for vasoplegic syndrome in cardiothoracic surgery: A retrospective cohort","volume":"34","author":"Furnish","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.jvca.2021.05.042","article-title":"Hydroxocobalamin or methylene blue for vasoplegic syndrome in adult cardiothoracic surgery","volume":"36","author":"Kram","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0026","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1053\/j.jvca.2023.07.015","article-title":"Hydroxocobalamin versus methylene blue for the treatment of vasoplegic shock associated with cardiopulmonary bypass","volume":"37","author":"Hiruy","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Syn Meth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0028","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.jvca.2023.04.006","article-title":"Hydroxocobalamin for vasodilatory hypotension in shock: A systematic review with meta-analysis for comparison to methylene blue","volume":"37","author":"Brokmeier","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0029","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1053\/j.jvca.2024.09.135_bib0030","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1053\/j.jvca.2024.09.135_bib0031","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00134-008-1279-1","article-title":"The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: A prospective, controlled study","volume":"35","author":"Jochberger","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0032","series-title":"(Hydroxocobalamin for injection) [prescribing information]","year":"2021"},{"key":"10.1053\/j.jvca.2024.09.135_bib0033","series-title":"(Methylene blue for injection) [prescribing information]","year":"2017"},{"key":"10.1053\/j.jvca.2024.09.135_bib0034","first-page":"14","article-title":"High-dose hydroxocobalamin for refractory vasoplegia post cardiac surgery","volume":"22","author":"Bak","year":"2022","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2024.09.135_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050312120935466","article-title":"Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies","volume":"8","author":"Barnes","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2024.09.135_bib0037","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0038","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1053\/j.jvca.2020.11.032","article-title":"Vasopressor therapy in cardiac surgery\u2014An experts\u2019 consensus statement","volume":"35","author":"Guarracino","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0039","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: A meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0040","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.jvca.2018.11.025","article-title":"A systematic approach to the treatment of vasoplegia based on recent advances in pharmacotherapy","volume":"33","author":"Ortoleva","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0041","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jtcvs.2021.02.097","article-title":"Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients","volume":"163","author":"Chow","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0042","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4274\/TJAR.2023.221093","article-title":"Vasoplegic syndrome and anaesthesia: A narrative review","volume":"51","author":"G\u00f6kdemir","year":"2023","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"10.1053\/j.jvca.2024.09.135_bib0043","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0044","first-page":"498","article-title":"PharmGKB summary: Methylene blue pathway","volume":"23","author":"McDonagh","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1053\/j.jvca.2024.09.135_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.jvca.2024.09.135_bib0046","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.bjp.0707430","article-title":"Methylene blue and serotonin toxicity: Inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction","volume":"152","author":"Ramsay","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.jvca.2024.09.135_bib0047","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0033-3182(10)70685-X","article-title":"The role of methylene blue in serotonin syndrome: A systematic review","volume":"51","author":"Ng","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1053\/j.jvca.2024.09.135_bib0048","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: A review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0049","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1053\/j.jvca.2023.02.035","article-title":"Hydroxocobalamin interference with chromogenic anti-Xa assay in a patient on mechanical circulatory support","volume":"37","author":"Cagle","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.jvca.2023.03.017","article-title":"Seeing red: Hydroxocobalamin and result interference","volume":"37","author":"Ortoleva","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0051","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0196-0644(94)70164-4","article-title":"Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies","volume":"24","author":"Curry","year":"1994","journal-title":"Ann Emerg Med"},{"key":"10.1053\/j.jvca.2024.09.135_bib0052","doi-asserted-by":"crossref","first-page":"e22089","DOI":"10.1002\/jcla.22089","article-title":"Hemolysis index to detect degree of hydroxocobalamin interference with common laboratory tests","volume":"31","author":"Fueyo","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"10.1053\/j.jvca.2024.09.135_bib0053","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.semdp.2008.12.008","article-title":"Laboratory interferences with the newer cyanide antidote: Hydroxocobalamin","volume":"26","author":"Beckerman","year":"2009","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.jvca.2024.09.135_bib0054","series-title":"Methylthioninium chloride, British National Formulary. 87","year":"2024"},{"key":"10.1053\/j.jvca.2024.09.135_bib0055","series-title":"Hydroxocobalamin, British National Formulary. 87","year":"2024"},{"key":"10.1053\/j.jvca.2024.09.135_bib0056","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"\u00d6zal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0057","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: Early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0058","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrtlng.2020.11.003","article-title":"Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery","volume":"50","author":"Seelhammer","year":"2021","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2024.09.135_bib0059","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1053\/j.jvca.2023.08.145","article-title":"Intraoperative versus postoperative hydroxocobalamin for vasoplegic shock in cardiothoracic surgery","volume":"37","author":"Khandekar","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0060","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1053\/j.jvca.2022.01.021","article-title":"Predicting the response of hydroxocobalamin in postoperative vasoplegia in recipients of cardiopulmonary bypass","volume":"36","author":"Vollmer","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.09.135_bib0061","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15563650600811755","article-title":"Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study","volume":"44","author":"Uhl","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2024.09.135_bib0062","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"Peter","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/j.jvca.2024.09.135_bib0063","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0003-4975(94)90249-6","article-title":"Nitric oxide formation during cardiopulmonary bypass","volume":"57","author":"Ruvolo","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.09.135_bib0064","unstructured":"Low YH. Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery. ClinicalTrials.gov identifier: NCT03446599. Accessed June 6, 2024. https:\/\/clinicaltrials.gov\/study\/NCT03446599."},{"key":"10.1053\/j.jvca.2024.09.135_bib0065","unstructured":"Badr DS. Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: NCT06160219. Accessed June 6, 2024. https:\/\/clinicaltrials.gov\/study\/NCT06160219."},{"key":"10.1053\/j.jvca.2024.09.135_bib0066","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/01.CIR.92.8.2226","article-title":"Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: A comparison of low-flow cardiopulmonary bypass and circulatory arrest","volume":"92","author":"Wernovsky","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.09.135_bib0067","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity","volume":"20","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0068","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: A scoping review and suggested formula","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2024.09.135_bib0069","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.jvca.2023.05.001","article-title":"Hydroxocobalamin in refractory vasodilatory shock: More questions than answers","volume":"37","author":"Kumar","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024007626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024007626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T03:27:10Z","timestamp":1733282830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024007626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1053077024007626"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.09.135","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxocobalamin Versus Methylene Blue for Treatment of Vasoplegic Shock Following Cardiopulmonary Bypass: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.09.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}